Sort by: Date added | Date Published | Most Viewed

Headlines Tagged with Vaccines 1,079 headlines found

5 Views

[California] Judge: Man Claiming Anti-Smoking Drug Made Him Gouge Out His Eyes Needs Stronger Case

ruled Thursday that a man who wants to sue the psychiatrist who prescribed him the anti-smoking drug Chantix will have to shore up his case before a lawsuit can move forward. The man, Michael Shabis, maintained the drug Chantix caused him to have a psych
CBS 2 News / KCAL 9 (Los Angeles, CA)
added Jul 22, 2016 23:48
3 Views

Use of nicotine patches or Zyban drug during pregnancy benefits both mother and child

The results of the study, published in the American Journal of Obstetrics and Gynecology, indicate that in 80% of cases, women who used nicotine patches or the drug Zyban successively quit smoking. Even after stopping the use of these products, 60% of Zy
News-Medical.net
added Jul 20, 2016 18:39
2 Views

Study finds differing treatment options for women smokers

reviewed and analyzed evidence from over 14,000 cigarette smokers participating in 28 clinical trials for nicotine patch, varenicline and bupropion, found that across the trials women who were given varenicline were much more likely to quit smoking than w
ScienceDaily
added Jul 14, 2016 15:31
3 Views

CCNY-led study finds differing treatment options for women smokers

clinical trials for nicotine patch, varenicline and bupropion, found that across the trials women who were given varenicline were much more likely to quit smoking than women who were given nicotine patch or bupropion. By contrast, among men there were no
EurekAlert
added Jul 13, 2016 18:27
7 Views

CHAMPIX® (Varenicline) European Union Label Updated To Include New Safety And Efficacy Data From The EAGLES Clinical Trial Following Endorsement From CHMP

Pfizer Inc. (NYSE:PFE) today announced that the European Summary of Product Characteristics (SmPC) and Package Leaflet for CHAMPIX® (varenicline) have been updated to include safety and efficacy data from the EAGLES (Evaluating Adverse Events in a Global
Pfizer
added May 24, 2016 15:46
4 Views

Europe lifts warning on Pfizer smoking cessation drug

European regulators have lifted a warning on Pfizer's smoking cessation drug Champix - called Chantix in the United States - after a clinical study concluded it did not appear to increase the risk of neuropsychiatric side effects.
Reuters
added May 23, 2016 18:45
18 Views

The FDA Needs To Change The Label For The Smoking Cessation Drug, Chantix

Forbes
added May 6, 2016 19:50
6 Views

Health: Study offers hope for stop-smoking drugs

Now Chantix maker Pfizer and Zyban maker GlaxoSmithKline hope the Food and Drug Administration, which ordered them to do the study, will remove the so-called “black box warnings” put on their prescription drugs due to anecdotal patient reports of serious
AP - Associated Press
added May 2, 2016 19:34
5 Views

Neuropsychiatric safety and efficacy of varenicline, bupropion, and nicotine patch in smokers with and without psychiatric disorders (EAGLES): a double-blind, randomised, placebo-controlled clinical trial

The study did not show a significant increase in neuropsychiatric adverse events attributable to varenicline or bupropion relative to nicotine patch or placebo. Varenicline was more effective than placebo, nicotine patch, and bupropion in helping smokers
The Lancet (uk)
added Apr 25, 2016 14:46
8 Views

Chantix, Wellbutrin Found Safe in Smokers with Psych Disorders

Smokers with psychiatric disorders who took the stop-smoking drug varenicline (Chantix) or the antidepressant bupropion (Wellbutrin) in an effort to kick the habit were no more likely to experience serious neuropsychiatric side effects than those who use
MedPage Today
added Apr 25, 2016 14:45
Sign up for daily headlines All Headlines Featured Headlines U.S. Headlines International Headlines